Global Therapeutic Nuclear Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 192584
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Therapeutic Nuclear Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Therapeutic Nuclear Drug size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Therapeutic Nuclear Drug market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Therapeutic Nuclear Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Radium-223

Lutetium-177

Iodine-131

Other

Market segment by Application, can be divided into

Thyroid

Bone Metastasis

Lymphoma

Other

Market segment by players, this report covers

Bayer

Novartis

China Isotope & Radiation

Dongcheng

Q BioMed

Curium Pharmaceuticals

Jubilant DraxImage

Lantheus

Spectrum Pharmaceuticals

Progenics Pharmaceuticals

International Isotopes

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Therapeutic Nuclear Drug

1.2 Classification of Therapeutic Nuclear Drug by Type

1.2.1 Overview: Global Therapeutic Nuclear Drug Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Therapeutic Nuclear Drug Revenue Market Share by Type in 2020

1.2.3 Radium-223

1.2.4 Lutetium-177

1.2.5 Iodine-131

1.2.6 Other

1.3 Global Therapeutic Nuclear Drug Market by Application

1.3.1 Overview: Global Therapeutic Nuclear Drug Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Thyroid

1.3.3 Bone Metastasis

1.3.4 Lymphoma

1.3.5 Other

1.4 Global Therapeutic Nuclear Drug Market Size & Forecast

1.5 Global Therapeutic Nuclear Drug Market Size and Forecast by Region

1.5.1 Global Therapeutic Nuclear Drug Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Therapeutic Nuclear Drug Market Size by Region, (2016-2021)

1.5.3 North America Therapeutic Nuclear Drug Market Size and Prospect (2016-2026)

1.5.4 Europe Therapeutic Nuclear Drug Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Therapeutic Nuclear Drug Market Size and Prospect (2016-2026)

1.5.6 South America Therapeutic Nuclear Drug Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Therapeutic Nuclear Drug Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Therapeutic Nuclear Drug Market Drivers

1.6.2 Therapeutic Nuclear Drug Market Restraints

1.6.3 Therapeutic Nuclear Drug Trends Analysis

2 Company Profiles

2.1 Bayer

2.1.1 Bayer Details

2.1.2 Bayer Major Business

2.1.3 Bayer Therapeutic Nuclear Drug Product and Solutions

2.1.4 Bayer Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Bayer Recent Developments and Future Plans

2.2 Novartis

2.2.1 Novartis Details

2.2.2 Novartis Major Business

2.2.3 Novartis Therapeutic Nuclear Drug Product and Solutions

2.2.4 Novartis Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Novartis Recent Developments and Future Plans

2.3 China Isotope & Radiation

2.3.1 China Isotope & Radiation Details

2.3.2 China Isotope & Radiation Major Business

2.3.3 China Isotope & Radiation Therapeutic Nuclear Drug Product and Solutions

2.3.4 China Isotope & Radiation Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 China Isotope & Radiation Recent Developments and Future Plans

2.4 Dongcheng

2.4.1 Dongcheng Details

2.4.2 Dongcheng Major Business

2.4.3 Dongcheng Therapeutic Nuclear Drug Product and Solutions

2.4.4 Dongcheng Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Dongcheng Recent Developments and Future Plans

2.5 Q BioMed

2.5.1 Q BioMed Details

2.5.2 Q BioMed Major Business

2.5.3 Q BioMed Therapeutic Nuclear Drug Product and Solutions

2.5.4 Q BioMed Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Q BioMed Recent Developments and Future Plans

2.6 Curium Pharmaceuticals

2.6.1 Curium Pharmaceuticals Details

2.6.2 Curium Pharmaceuticals Major Business

2.6.3 Curium Pharmaceuticals Therapeutic Nuclear Drug Product and Solutions

2.6.4 Curium Pharmaceuticals Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Curium Pharmaceuticals Recent Developments and Future Plans

2.7 Jubilant DraxImage

2.7.1 Jubilant DraxImage Details

2.7.2 Jubilant DraxImage Major Business

2.7.3 Jubilant DraxImage Therapeutic Nuclear Drug Product and Solutions

2.7.4 Jubilant DraxImage Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Jubilant DraxImage Recent Developments and Future Plans

2.8 Lantheus

2.8.1 Lantheus Details

2.8.2 Lantheus Major Business

2.8.3 Lantheus Therapeutic Nuclear Drug Product and Solutions

2.8.4 Lantheus Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Lantheus Recent Developments and Future Plans

2.9 Spectrum Pharmaceuticals

2.9.1 Spectrum Pharmaceuticals Details

2.9.2 Spectrum Pharmaceuticals Major Business

2.9.3 Spectrum Pharmaceuticals Therapeutic Nuclear Drug Product and Solutions

2.9.4 Spectrum Pharmaceuticals Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Spectrum Pharmaceuticals Recent Developments and Future Plans

2.10 Progenics Pharmaceuticals

2.10.1 Progenics Pharmaceuticals Details

2.10.2 Progenics Pharmaceuticals Major Business

2.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Drug Product and Solutions

2.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Progenics Pharmaceuticals Recent Developments and Future Plans

2.11 International Isotopes

2.11.1 International Isotopes Details

2.11.2 International Isotopes Major Business

2.11.3 International Isotopes Therapeutic Nuclear Drug Product and Solutions

2.11.4 International Isotopes Therapeutic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 International Isotopes Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Therapeutic Nuclear Drug Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Therapeutic Nuclear Drug Players Market Share

3.2.2 Top 10 Therapeutic Nuclear Drug Players Market Share

3.2.3 Market Competition Trend

3.3 Therapeutic Nuclear Drug Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Therapeutic Nuclear Drug Revenue and Market Share by Type (2016-2021)

4.2 Global Therapeutic Nuclear Drug Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Therapeutic Nuclear Drug Revenue Market Share by Application (2016-2021)

5.2 Therapeutic Nuclear Drug Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Therapeutic Nuclear Drug Revenue by Type (2016-2026)

6.2 North America Therapeutic Nuclear Drug Revenue by Application (2016-2026)

6.3 North America Therapeutic Nuclear Drug Market Size by Country

6.3.1 North America Therapeutic Nuclear Drug Revenue by Country (2016-2026)

6.3.2 United States Therapeutic Nuclear Drug Market Size and Forecast (2016-2026)

6.3.3 Canada Therapeutic Nuclear Drug Market Size and Forecast (2016-2026)

6.3.4 Mexico Therapeutic Nuclear Drug Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Therapeutic Nuclear Drug Revenue by Type (2016-2026)

7.2 Europe Therapeutic Nuclear Drug Revenue by Application (2016-2026)

7.3 Europe Therapeutic Nuclear Drug Market Size by Country

7.3.1 Europe Therapeutic Nuclear Drug Revenue by Country (2016-2026)

7.3.2 Germany Therapeutic Nuclear Drug Market Size and Forecast (2016-2026)

7.3.3 France Therapeutic Nuclear Drug Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Therapeutic Nuclear Drug Market Size and Forecast (2016-2026)

7.3.5 Russia Therapeutic Nuclear Drug Market Size and Forecast (2016-2026)

7.3.6 Italy Therapeutic Nuclear Drug Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Therapeutic Nuclear Drug Revenue by Type (2016-2026)

8.2 Asia-Pacific Therapeutic Nuclear Drug Revenue by Application (2016-2026)

8.3 Asia-Pacific Therapeutic Nuclear Drug Market Size by Region

8.3.1 Asia-Pacific Therapeutic Nuclear Drug Revenue by Region (2016-2026)

8.3.2 China Therapeutic Nuclear Drug Market Size and Forecast (2016-2026)

8.3.3 Japan Therapeutic Nuclear Drug Market Size and Forecast (2016-2026)

8.3.4 South Korea Therapeutic Nuclear Drug Market Size and Forecast (2016-2026)

8.3.5 India Therapeutic Nuclear Drug Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Therapeutic Nuclear Drug Market Size and Forecast (2016-2026)

8.3.7 Australia Therapeutic Nuclear Drug Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Therapeutic Nuclear Drug Revenue by Type (2016-2026)

9.2 South America Therapeutic Nuclear Drug Revenue by Application (2016-2026)

9.3 South America Therapeutic Nuclear Drug Market Size by Country

9.3.1 South America Therapeutic Nuclear Drug Revenue by Country (2016-2026)

9.3.2 Brazil Therapeutic Nuclear Drug Market Size and Forecast (2016-2026)

9.3.3 Argentina Therapeutic Nuclear Drug Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Therapeutic Nuclear Drug Revenue by Type (2016-2026)

10.2 Middle East & Africa Therapeutic Nuclear Drug Revenue by Application (2016-2026)

10.3 Middle East & Africa Therapeutic Nuclear Drug Market Size by Country

10.3.1 Middle East & Africa Therapeutic Nuclear Drug Revenue by Country (2016-2026)

10.3.2 Turkey Therapeutic Nuclear Drug Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Therapeutic Nuclear Drug Market Size and Forecast (2016-2026)

10.3.4 UAE Therapeutic Nuclear Drug Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Therapeutic Nuclear Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Therapeutic Nuclear Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Therapeutic Nuclear Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Therapeutic Nuclear Drug Revenue (USD Million) by Region (2016-2021)

Table 5. Global Therapeutic Nuclear Drug Revenue Market Share by Region (2021-2026)

Table 6. Bayer Corporate Information, Head Office, and Major Competitors

Table 7. Bayer Major Business

Table 8. Bayer Therapeutic Nuclear Drug Product and Solutions

Table 9. Bayer Therapeutic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Novartis Corporate Information, Head Office, and Major Competitors

Table 11. Novartis Major Business

Table 12. Novartis Therapeutic Nuclear Drug Product and Solutions

Table 13. Novartis Therapeutic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. China Isotope & Radiation Corporate Information, Head Office, and Major Competitors

Table 15. China Isotope & Radiation Major Business

Table 16. China Isotope & Radiation Therapeutic Nuclear Drug Product and Solutions

Table 17. China Isotope & Radiation Therapeutic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Dongcheng Corporate Information, Head Office, and Major Competitors

Table 19. Dongcheng Major Business

Table 20. Dongcheng Therapeutic Nuclear Drug Product and Solutions

Table 21. Dongcheng Therapeutic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Q BioMed Corporate Information, Head Office, and Major Competitors

Table 23. Q BioMed Major Business

Table 24. Q BioMed Therapeutic Nuclear Drug Product and Solutions

Table 25. Q BioMed Therapeutic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Curium Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 27. Curium Pharmaceuticals Major Business

Table 28. Curium Pharmaceuticals Therapeutic Nuclear Drug Product and Solutions

Table 29. Curium Pharmaceuticals Therapeutic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Jubilant DraxImage Corporate Information, Head Office, and Major Competitors

Table 31. Jubilant DraxImage Major Business

Table 32. Jubilant DraxImage Therapeutic Nuclear Drug Product and Solutions

Table 33. Jubilant DraxImage Therapeutic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Lantheus Corporate Information, Head Office, and Major Competitors

Table 35. Lantheus Major Business

Table 36. Lantheus Therapeutic Nuclear Drug Product and Solutions

Table 37. Lantheus Therapeutic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Spectrum Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 39. Spectrum Pharmaceuticals Major Business

Table 40. Spectrum Pharmaceuticals Therapeutic Nuclear Drug Product and Solutions

Table 41. Spectrum Pharmaceuticals Therapeutic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Progenics Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 43. Progenics Pharmaceuticals Major Business

Table 44. Progenics Pharmaceuticals Therapeutic Nuclear Drug Product and Solutions

Table 45. Progenics Pharmaceuticals Therapeutic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. International Isotopes Corporate Information, Head Office, and Major Competitors

Table 47. International Isotopes Major Business

Table 48. International Isotopes Therapeutic Nuclear Drug Product and Solutions

Table 49. International Isotopes Therapeutic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Global Therapeutic Nuclear Drug Revenue (USD Million) by Players (2019-2021)

Table 51. Global Therapeutic Nuclear Drug Revenue Share by Players (2019-2021)

Table 52. Breakdown of Therapeutic Nuclear Drug by Company Type (Tier 1, Tier 2 and Tier 3)

Table 53. Therapeutic Nuclear Drug Players Head Office, Products and Services Provided

Table 54. Therapeutic Nuclear Drug Mergers & Acquisitions in the Past Five Years

Table 55. Therapeutic Nuclear Drug New Entrants and Expansion Plans

Table 56. Global Therapeutic Nuclear Drug Revenue (USD Million) by Type (2016-2021)

Table 57. Global Therapeutic Nuclear Drug Revenue Share by Type (2016-2021)

Table 58. Global Therapeutic Nuclear Drug Revenue Forecast by Type (2021-2026)

Table 59. Global Therapeutic Nuclear Drug Revenue by Application (2016-2021)

Table 60. Global Therapeutic Nuclear Drug Revenue Forecast by Application (2021-2026)

Table 61. North America Therapeutic Nuclear Drug Revenue by Type (2016-2021) & (USD Million)

Table 62. North America Therapeutic Nuclear Drug Revenue by Type (2021-2026) & (USD Million)

Table 63. North America Therapeutic Nuclear Drug Revenue by Application (2016-2021) & (USD Million)

Table 64. North America Therapeutic Nuclear Drug Revenue by Application (2021-2026) & (USD Million)

Table 65. North America Therapeutic Nuclear Drug Revenue by Country (2016-2021) & (USD Million)

Table 66. North America Therapeutic Nuclear Drug Revenue by Country (2021-2026) & (USD Million)

Table 67. Europe Therapeutic Nuclear Drug Revenue by Type (2016-2021) & (USD Million)

Table 68. Europe Therapeutic Nuclear Drug Revenue by Type (2021-2026) & (USD Million)

Table 69. Europe Therapeutic Nuclear Drug Revenue by Application (2016-2021) & (USD Million)

Table 70. Europe Therapeutic Nuclear Drug Revenue by Application (2021-2026) & (USD Million)

Table 71. Europe Therapeutic Nuclear Drug Revenue by Country (2016-2021) & (USD Million)

Table 72. Europe Therapeutic Nuclear Drug Revenue by Country (2021-2026) & (USD Million)

Table 73. Asia-Pacific Therapeutic Nuclear Drug Revenue by Type (2016-2021) & (USD Million)

Table 74. Asia-Pacific Therapeutic Nuclear Drug Revenue by Type (2021-2026) & (USD Million)

Table 75. Asia-Pacific Therapeutic Nuclear Drug Revenue by Application (2016-2021) & (USD Million)

Table 76. Asia-Pacific Therapeutic Nuclear Drug Revenue by Application (2021-2026) & (USD Million)

Table 77. Asia-Pacific Therapeutic Nuclear Drug Revenue by Region (2016-2021) & (USD Million)

Table 78. Asia-Pacific Therapeutic Nuclear Drug Revenue by Region (2021-2026) & (USD Million)

Table 79. South America Therapeutic Nuclear Drug Revenue by Type (2016-2021) & (USD Million)

Table 80. South America Therapeutic Nuclear Drug Revenue by Type (2021-2026) & (USD Million)

Table 81. South America Therapeutic Nuclear Drug Revenue by Application (2016-2021) & (USD Million)

Table 82. South America Therapeutic Nuclear Drug Revenue by Application (2021-2026) & (USD Million)

Table 83. South America Therapeutic Nuclear Drug Revenue by Country (2016-2021) & (USD Million)

Table 84. South America Therapeutic Nuclear Drug Revenue by Country (2021-2026) & (USD Million)

Table 85. Middle East & Africa Therapeutic Nuclear Drug Revenue by Type (2016-2021) & (USD Million)

Table 86. Middle East & Africa Therapeutic Nuclear Drug Revenue by Type (2021-2026) & (USD Million)

Table 87. Middle East & Africa Therapeutic Nuclear Drug Revenue by Application (2016-2021) & (USD Million)

Table 88. Middle East & Africa Therapeutic Nuclear Drug Revenue by Application (2021-2026) & (USD Million)

Table 89. Middle East & Africa Therapeutic Nuclear Drug Revenue by Country (2016-2021) & (USD Million)

Table 90. Middle East & Africa Therapeutic Nuclear Drug Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Therapeutic Nuclear Drug Picture

Figure 2. Global Therapeutic Nuclear Drug Revenue Market Share by Type in 2020

Figure 3. Radium-223

Figure 4. Lutetium-177

Figure 5. Iodine-131

Figure 6. Other

Figure 7. Therapeutic Nuclear Drug Revenue Market Share by Application in 2020

Figure 8. Thyroid Picture

Figure 9. Bone Metastasis Picture

Figure 10. Lymphoma Picture

Figure 11. Other Picture

Figure 12. Global Therapeutic Nuclear Drug Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 13. Global Therapeutic Nuclear Drug Revenue and Forecast (2016-2026) & (USD Million)

Figure 14. Global Therapeutic Nuclear Drug Revenue Market Share by Region (2016-2026)

Figure 15. Global Therapeutic Nuclear Drug Revenue Market Share by Region in 2020

Figure 16. North America Therapeutic Nuclear Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Europe Therapeutic Nuclear Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Asia-Pacific Therapeutic Nuclear Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. South America Therapeutic Nuclear Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Middle East and Africa Therapeutic Nuclear Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Therapeutic Nuclear Drug Market Drivers

Figure 22. Therapeutic Nuclear Drug Market Restraints

Figure 23. Therapeutic Nuclear Drug Market Trends

Figure 24. Bayer Recent Developments and Future Plans

Figure 25. Novartis Recent Developments and Future Plans

Figure 26. China Isotope & Radiation Recent Developments and Future Plans

Figure 27. Dongcheng Recent Developments and Future Plans

Figure 28. Q BioMed Recent Developments and Future Plans

Figure 29. Curium Pharmaceuticals Recent Developments and Future Plans

Figure 30. Jubilant DraxImage Recent Developments and Future Plans

Figure 31. Lantheus Recent Developments and Future Plans

Figure 32. Spectrum Pharmaceuticals Recent Developments and Future Plans

Figure 33. Progenics Pharmaceuticals Recent Developments and Future Plans

Figure 34. International Isotopes Recent Developments and Future Plans

Figure 35. Global Therapeutic Nuclear Drug Revenue Share by Players in 2020

Figure 36. Therapeutic Nuclear Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 37. Global Top 3 Players Therapeutic Nuclear Drug Revenue Market Share in 2020

Figure 38. Global Top 10 Players Therapeutic Nuclear Drug Revenue Market Share in 2020

Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 40. Global Therapeutic Nuclear Drug Revenue Share by Type in 2020

Figure 41. Global Therapeutic Nuclear Drug Market Share Forecast by Type (2021-2026)

Figure 42. Global Therapeutic Nuclear Drug Revenue Share by Application in 2020

Figure 43. Global Therapeutic Nuclear Drug Market Share Forecast by Application (2021-2026)

Figure 44. North America Therapeutic Nuclear Drug Sales Market Share by Type (2016-2026)

Figure 45. North America Therapeutic Nuclear Drug Sales Market Share by Application (2016-2026)

Figure 46. North America Therapeutic Nuclear Drug Revenue Market Share by Country (2016-2026)

Figure 47. United States Therapeutic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Canada Therapeutic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Mexico Therapeutic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Europe Therapeutic Nuclear Drug Sales Market Share by Type (2016-2026)

Figure 51. Europe Therapeutic Nuclear Drug Sales Market Share by Application (2016-2026)

Figure 52. Europe Therapeutic Nuclear Drug Revenue Market Share by Country (2016-2026)

Figure 53. Germany Therapeutic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. France Therapeutic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. United Kingdom Therapeutic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Russia Therapeutic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Italy Therapeutic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Asia-Pacific Therapeutic Nuclear Drug Sales Market Share by Type (2016-2026)

Figure 59. Asia-Pacific Therapeutic Nuclear Drug Sales Market Share by Application (2016-2026)

Figure 60. Asia-Pacific Therapeutic Nuclear Drug Revenue Market Share by Region (2016-2026)

Figure 61. China Therapeutic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Japan Therapeutic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. South Korea Therapeutic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. India Therapeutic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Southeast Asia Therapeutic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Australia Therapeutic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. South America Therapeutic Nuclear Drug Sales Market Share by Type (2016-2026)

Figure 68. South America Therapeutic Nuclear Drug Sales Market Share by Application (2016-2026)

Figure 69. South America Therapeutic Nuclear Drug Revenue Market Share by Country (2016-2026)

Figure 70. Brazil Therapeutic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Argentina Therapeutic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Middle East and Africa Therapeutic Nuclear Drug Sales Market Share by Type (2016-2026)

Figure 73. Middle East and Africa Therapeutic Nuclear Drug Sales Market Share by Application (2016-2026)

Figure 74. Middle East and Africa Therapeutic Nuclear Drug Revenue Market Share by Country (2016-2026)

Figure 75. Turkey Therapeutic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Saudi Arabia Therapeutic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. UAE Therapeutic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Methodology

Figure 79. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz